GrantRover ↗

← All opportunities

EP PerMed · European Union

Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)

Open

Applications close on 20 Jan 2027 (EU calls usually close at 17:00 Brussels time). Organisations in EU member states and Horizon Europe associated countries such as Türkiye can usually take part; the topic conditions control.

Deadline
20 Jan 2027 (in 66 days)
Grant amount
€37 million total budget (amount per applicant not stated)
Funding rate
Set by the call (financial support to third parties, often lump sums)
Likely applicant types
SMEs / start-ups, Companies, Non-profits, Universities & research From source categories or programme rules; the call decides.
Funder
EP PerMed (EU-funded project)
Reference
HORIZON-HLTH-2023-CARE-08-01
Last checked
15 Nov 2026

Open the official call ↗ Add deadline to calendar

Who can apply

All information and documents concerning the EP PerMed Joint Transnational Call (JTC) 2027, including the call text outlining the aims and scope of the call, the Guidelines for Applicants document, the pre-proposal form, etc. can be found here: https://www.eppermed.eu/funding-projects/calls/jtc2027/ .

Electronic submission system: https://ptoutline.eu/app/eppermed2027 .

Deadline to submit pre-proposals: 20 January 2027 (14:00, CET)

Deadline to submit full proposals: 25 May 2027 (14:00, CEST)

Applicant categories are a starting point. The official call decides eligibility.

Timing

Next deadline 2027-01-20. Check the call page for the exact time.

How to apply

  1. This is an open call run by an EU-funded project, not an EU Funding & Tenders Portal topic: you apply to the project, usually on its own platform. A PIC or Part A/Part B forms are not needed unless the call says so.
  2. Application route stated in the call: “Electronic submission system: https://ptoutline.eu/app/eppermed2027 .”
  3. Read the call guidelines for who can apply, eligible countries and the support per applicant (financial support to third parties is often a lump sum or capped amount).
  4. Submit before the deadline shown above; check the call page for the exact time zone.

Guide: how open calls by EU-funded projects work, and all calls open now

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Electronic submission system: https://ptoutline.eu/app/eppermed2027 .

Read the EU application guide

Where these facts come from

FactValueHow we knowTaken from the source
Deadline20 January 2027
“Next deadline 2027-01-20. Check the call page for the exact time.”
official data field15 Nov 2026
Amount per applicantUnknown — not stated in the source we holdunknown—
Total budgetUnknown — not stated in the source we holdunknown—
Funding rateUnknown — not stated in the source we holdunknown—
Who can applyAll information and documents concerning the EP PerMed Joint Transnational Call (JTC) 2027, including the call text outlining the aims and scope of the call, the Guidelines for Applicants document, the pre-proposal…read from the official text15 Nov 2026
Where to applyElectronic submission system: https://ptoutline.eu/app/eppermed2027 .read from the official text15 Nov 2026

Official sources

Official call page

Facts on this page come from the funder’s official data, taken on 15 Nov 2026. The funder's own documents, including later amendments, always take precedence.

Related funding

BATTLEVERSE European Union

Open Call for Cutting-Edge Defence Solutions

EDF-2024-RA-SIMTRAIN-BRG-STEP

DUT European Union

Driving Urban Transitions (DUT) Call 2026

HORIZON-CL5-2021-D2-01-16

Horizon Europe European Union

Neutral-Atom Platform Technologies

HORIZON-JU-EUROHPC-2026-NAPT-11-01

This action aims to establish European leadership in neutral-atom quantum simulation and digital quantum computing by delivering: • Fully programmable industry-ready quan…